Delivery Order SPE2DB22D3301-SPE2DB25FX4VR

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,246.26 firm-fixed-price delivery order is for the supply of Depo-Estradiol 5 mg/ml vials. The contract has a period of performance through November 4, 2024 and was awarded on November 1, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,251.69 Firm Fixed Price delivery order is for the supply of Depo-Estradiol 5 mg/ml vials. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,154.29 firm fixed-price delivery order is for the supply of DEPO-ESTRADIOL 5 MG/ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2022 and was awarded on March 2, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,105.92 firm-fixed-price contract is for the delivery of ESTRADIOL 0.075MG 8S, a pharmaceutical product, with a period of performance through February 2025. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 10 MCG Vaginal Inserts. The $1,547.31 contract has a completion date of November 20, 2024 and was awarded on November 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $3,083.14 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ESTRADIOL VALERATE 100 MG/5 ML 5ML, a pharmaceutical product, with a completion date of January 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,422.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Estradiol Valerate 200 mg/5 ml, 5 ml, with a period of performance through February 27, 2025. The contract is not associated with any set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,580.94 to supply Depo-Estradiol 5 mg/ml vial 5ml. The contract has a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Estradiol 0.06% 1.25g gel pump, 37.5g, with a total ceiling value of $1,288.29. The contract type is firm fixed price, and the ultimate completion date is May 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $22,496.67, is for the delivery of Estradiol 10 MCG Vaginal Insert, a prescription medication. The contract has an ultimate completion date of January 9, 2025 and is a firm-fixed-price contract. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4VR
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,290.95, is for the delivery of Depo-Estradiol 5 mg/ml vials, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. No set-aside designation was used in this award.

Generated 1/31/25, 9:30 AM